IP Verse

Glaxosmithkline Intellectual Property Development Limited opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Glaxosmithkline Intellectual Property Development Limited

Patent Number:
EP3653221
Title:
Anti-Pvrig Antibodies And Methods Of Use
Applicant:
COMPUGEN LTD.
Opposition Date:
May 2, 2023
Patent Number:
EP3259597
Title:
Pvrig Polypeptides And Methods Of Treatment
Applicant:
COMPUGEN LTD.
Opposition Date:
Jan 5, 2023
Patent Number:
EP2997036
Title:
Purification Of Recombinantly Produced Polypeptides
Applicant:
MEDIMMUNE LIMITED
Opposition Date:
Dec 3, 2021
Patent Number:
EP3616720
Title:
Pharmaceutical Composition For Cancer Treatment
Applicant:
OSAKA UNIVERSITY
Opposition Date:
Nov 17, 2021
Patent Number:
EP3137186
Title:
Methods For The Purification Of Proteins Using Caprylic Acid
Applicant:
NOVO NORDISK A/S
Opposition Date:
Oct 26, 2021
Patent Number:
EP3377618
Title:
Buffers For Stabilization Of Lentiviral Preparations
Applicant:
NOVARTIS AG
Opposition Date:
Aug 12, 2021
Patent Number:
EP3294770
Title:
Therapeutic And Diagnostic Methods For Cancer
Applicant:
F. HOFFMANN-LA ROCHE AG
Opposition Date:
Jul 7, 2021
Patent Number:
EP3134095
Title:
Improved Methods For Manufacturing Adoptive Cell Therapies
Applicant:
2SEVENTY BIO, INC.
Opposition Date:
Jan 21, 2021
Patent Number:
EP3303632
Title:
Therapeutic And Diagnostic Methods For Cancer
Applicant:
F. HOFFMANN-LA ROCHE AG
Opposition Date:
Dec 4, 2020
Patent Number:
EP3431105
Title:
Medicinal Composition For Treating Cancer
Applicant:
OSAKA UNIVERSITY
Opposition Date:
Sep 30, 2020

Latest patents of Glaxosmithkline Intellectual Property Development Limited opposed by its competitors

Patent:
EP3650019
Grant Date:
Oct 11, 2023
Title:
Fluticasone Furoate In The Treatment Of Copd
Oppositions:
3
Patent:
EP3297605
Grant Date:
May 4, 2022
Title:
Topical Pharmaceutical Compositions
Oppositions:
1
Patent:
EP3461474
Grant Date:
Nov 11, 2020
Title:
Dry Powder Inhalation Drug Products Exhibiting Moisture Control Properties And Methods Of Administering The Same
Oppositions:
4
Patent:
EP3481838
Grant Date:
Aug 19, 2020
Title:
Novel Processes For The Production Of Oligonucleotides
Oppositions:
2
Patent:
EP3148521
Grant Date:
Dec 18, 2019
Title:
Fluticasone Furoate In The Treatment Of Copd
Oppositions:
2
Patent:
EP2969098
Grant Date:
Oct 30, 2019
Title:
Methods For Purifying Antibodies
Oppositions:
1
Patent:
EP2611422
Grant Date:
Oct 31, 2018
Title:
Dry Powder Inhalation Drug Products Exhibiting Moisture Control Properties And Methods Of Administering The Same
Oppositions:
3

Competitors of Glaxosmithkline Intellectual Property Development Limited

SANDOZ AG

TEVA UK LIMITED

F. HOFFMANN-LA ROCHE AG

Want to track Glaxosmithkline Intellectual Property Development Limited?

Feel free to send us a message here and we will get back to you